Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase NA 18Phase 1 12Phase 3 5Phase EARLY_PHASE1 3Phase 2/3 3Phase 1/2 3

Status

Recruiting 3Unknown 2

Sponsor Class

OTHER 3OTHER_GOV 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 3Genitourinary 2Thoracic 1

Conditions

Prostatic Neoplasms 2Stomach Neoplasms 1Psychological Well-Being 1Pancreatic Neoplasms 1Motor Activity 1Lung Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Curcumin × Clear all
NCT02064673 2026-03-30

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

University of Texas Southwestern Medical Center

Phase 3 Recruiting
650 enrolled
Genitourinary

Prostatic Neoplasms

NCT04871412 2026-01-30

POISE

Ottawa Hospital Research Institute

Phase 3 Recruiting
20 enrolled
GastrointestinalThoracic

Psychological Well-Being, Esophageal Neoplasms, Lung Neoplasms, Motor Activity, Stomach Neoplasms

NCT03769766 2025-06-11

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

University of Texas Southwestern Medical Center

Phase 3 Recruiting
291 enrolled
Genitourinary

Prostatic Neoplasms

NCT00486460 2007-06-14

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Tel-Aviv Sourasky Medical Center

Phase 3 Unknown
Gastrointestinal

Pancreatic Neoplasms

NCT00295035 2006-02-22

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer

Tel-Aviv Sourasky Medical Center

Phase 3 Unknown
100 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡